Skip to main content
. 2007;25(10):1075–1077. doi: 10.1038/nbt1007-1075

Figure 1. Engineering tour de force—the Xenomouse.

Figure 1

Inactivating the mouse's own antibody genes while supplying human counterparts has led to the first fully human mAb drug made in a transgenic mouse. Source: Aya Jakobovitz.